Adverse events associated with rhGH use.

Based on the U.S. Food and Drug Administration (FDA) FDA Adverse Event Reporting System (FAERS) database, to analyze the adverse events (AEs) associated with Recombinant human growth hormone (rhGH), and to provide a reference for the safe use of the drug in clinical practice.